Bilha Fischer Selected Research

nucleotide pyrophosphatase

1/2018	Inhibition of nucleotide pyrophosphatase/phosphodiesterase 1: implications for developing a calcium pyrophosphate deposition disease modifying drug.
6/2014	Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffold.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bilha Fischer Research Topics

Disease

6	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2013
6	Alzheimer Disease (Alzheimer's Disease) 01/2017 - 07/2008
4	Neoplasms (Cancer) 01/2020 - 05/2013
3	Type 2 Diabetes Mellitus (MODY) 12/2019 - 09/2012
3	Osteoarthritis 01/2018 - 09/2013
2	Aortic Valve Disease 12/2019 - 01/2019
2	Glaucoma 01/2018 - 04/2010
2	Chondrocalcinosis (Pseudogout) 01/2018 - 06/2014
2	Inflammation (Inflammations) 07/2014 - 05/2013
2	Thrombosis (Thrombus) 07/2014 - 05/2013
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2013 - 01/2013
1	Chondrocalcinosis 2 12/2019
1	Arthritis (Polyarthritis) 11/2019
1	Prion Diseases (Transmissible Spongiform Encephalopathies) 07/2019
1	Joint Diseases (Joint Disease) 01/2019
1	Retinoblastoma (Glioblastoma, Retinal) 01/2018
1	Astrocytoma (Pilocytic Astrocytoma) 08/2014
1	Brain Injuries (Brain Injury) 06/2013
1	Hemorrhage 09/2012
1	Colonic Neoplasms (Colon Cancer) 12/2010
1	Asthma (Bronchial Asthma) 04/2010
1	Confusion (Bewilderment) 05/2009
1	Amyloid Plaque 05/2009

Drug/Important Bio-Agent (IBA)

5	Messenger RNA (mRNA)IBA 01/2020 - 06/2013
5	Pharmaceutical PreparationsIBA 11/2019 - 09/2012
4	Amyloid beta-PeptidesIBA 05/2016 - 07/2008
3	NucleotidesIBA 12/2019 - 05/2013
3	ZincIBA 01/2017 - 07/2012
3	IonsIBA 01/2017 - 07/2012
3	Chelating AgentsIBA 05/2016 - 01/2013
3	Cyclin D1IBA 05/2014 - 06/2013
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2014
2	Oligonucleotide ProbesIBA 01/2020 - 07/2019
2	DNA ProbesIBA 01/2020 - 06/2013
2	Calcium PyrophosphateIBA 01/2019 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 07/2014
2	nucleotide pyrophosphataseIBA 01/2018 - 06/2014
2	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018 - 06/2014
2	CopperIBA 01/2017 - 07/2012
2	MetalsIBA 01/2017 - 05/2016
2	AntioxidantsIBA 05/2016 - 05/2009
2	CD39 antigenIBA 07/2014 - 05/2013
2	Peptides (Polypeptides)IBA 07/2012 - 05/2009
1	Intercalating AgentsIBA 01/2020
1	NucleosidesIBA 01/2020
1	PrionsIBA 07/2019
1	methylphosphonic acid (methylphosphonate)IBA 07/2019
1	LigandsIBA 07/2019
1	Prion ProteinsIBA 07/2019
1	Peptide FragmentsIBA 07/2019
1	Diphosphates (Pyrophosphates)IBA 01/2019
1	diphosphoric acid (pyrophosphoric acid)IBA 01/2019
1	BromidesIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 01/2017
1	purinoceptor P2Y6IBA 08/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2014
1	ectoATPaseIBA 07/2014
1	8-(p-CF3-cinnamyl)-adenosineIBA 05/2014
1	OligonucleotidesIBA 05/2014
1	OligodeoxyribonucleotidesIBA 06/2013
1	Neuroprotective AgentsIBA 06/2013
1	IronIBA 01/2013
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2012
1	Blood Glucose (Blood Sugar)IBA 09/2012
1	Thymidine Monophosphate (TMP)IBA 12/2010
1	Timolol (Blocadren)FDA LinkGeneric 04/2010
1	Reactive Oxygen Species (Oxygen Radicals)IBA 05/2009

Therapy/Procedure

1	Immunotherapy 01/2019
1	Therapeutics 05/2016
1	Oral Administration 09/2012